Shares of Lupin rose 2% intraday on March 27 after the drugmaker received preliminary approval from the US Food and Drug Administration (USFDA) for Valbenazine...
On March 21, Pharma major Lupin shares increased 1.6% in the early trade after the company’s alliance partner Caplin Steriles got two final approvals from...
Lupin shares rose in early trading on March 14 after receiving a “no observation” certificate from the US Food and Drug Administration (USFDA). At 9:16...
On Friday, Pharmaceutical company Lupin said that it has partnered with Unitaid, the Aurum Institute, the Clinton Health Access Initiative (CHAI) and other global procurement...
On Tuesday, drug company Lupin said it had received approval from the US health regulator USFDA to market Darunavir Tablets in the American market. These...
On Thursday, India-based Global pharmaceutical company Lupin Limited announced the launch of Sildenafil for oral suspension, 10 mg/mL, after receiving approval from the United States...
Drugmaker Lupin said on Wednesday it had received preliminary approval from US health regulators to sell Ivacaftor tablets for cystic fibrosis in the US. In...
Pharmaceutical company Lupin said on Monday it had received approval from US health regulators to market its Tenofovir Alafenamide tablets to treat chronic hepatitis B...